<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03447223</url>
  </required_header>
  <id_info>
    <org_study_id>KY20182002-1</org_study_id>
    <nct_id>NCT03447223</nct_id>
  </id_info>
  <brief_title>Gut Microbiome and Serum Metabolome Alterations in ADHD Patients</brief_title>
  <acronym>ADHD</acronym>
  <official_title>Gut Microbiome and Serum Metabolome Alterations in Attention-deficit/Hyperactivity Disorder Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Host-microbe interactions play a key role in brain development and function and in the&#xD;
      etiology of neurodevelopmental disorders. Attention-deficit/hyperactivity disorder (ADHD) is&#xD;
      a heterogeneous disorder that affects 1 in 20 children and results in poor life-time&#xD;
      outcomes. However, the etiology of ADHD is unclear and its diagnosis and treatment are still&#xD;
      challenging. Different factors reported to be associated with the risk of developing ADHD&#xD;
      and/or linked to different ADHD manifestations have also been linked to shifts in gut&#xD;
      microbiota composition, suggesting a link between the microbiota and the disorder. Here, we&#xD;
      will perform a metagenome-wide association study and serum metabolomics profiling in a cohort&#xD;
      of control and ADHD, 6-15 years, Chinese individuals. We aim to identify ADHD-associated gut&#xD;
      microbial species linked to changes in circulating metabolites. We also aim to find the&#xD;
      possible intervention strategy in ADHD by targeting the gut microbiota.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 20, 2018</start_date>
  <completion_date type="Actual">May 27, 2020</completion_date>
  <primary_completion_date type="Actual">February 27, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ADHD-associated gut microbial species alterations</measure>
    <time_frame>2018-2020</time_frame>
    <description>Gut metagenome analysis with fecal samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ADHD-associated circulating metabolites alterations</measure>
    <time_frame>2018-2020</time_frame>
    <description>Circulation metabonomics analysis with serum samples</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">207</enrollment>
  <condition>Attention-deficit/Hyperactivity Disorder</condition>
  <arm_group>
    <arm_group_label>ADHD-patients</arm_group_label>
    <description>The children and adolescent 6-15 years old with ADHD. Diagnoses of the children with ADHD were made in Xijing Hospital according to criteria described in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Children with ADHD had an IQ score above 70.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls-healthy children</arm_group_label>
    <description>Age- and gender- matched healthy 6-15 years old children and adolescent.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood samples: serum metabolomics analyses; faeces: gut metagenome analyses&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All subjects were drug-naive at the time of recruitment, and the ADHD tests were&#xD;
        administered before the subjects were given any medication. The subjects will be recruited&#xD;
        from Xijing Hospital and elementary and secondary schools in China.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Diagnoses of the children with ADHD were made in Xijing Hospital according to criteria&#xD;
        described in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Children&#xD;
        with ADHD had an IQ score above 70.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Children who had a past history of or were currently affected by neurological diseases,&#xD;
        including convulsive disorders or brain damage; or who had any evidence of comorbid&#xD;
        psychiatric conditions, such as Tourette's syndrome, IQ below 70, pervasive developmental&#xD;
        disorder (autism), bipolar disorder, psychosis, language difficulties or learning disorders&#xD;
        (reading disorders, mathematics disorders and disorders of written expression).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lize Xiong, M.D./Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor and President, Xijing Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>https://en.wikipedia.org/wiki/Attention_deficit_hyperactivity_disorder</url>
    <description>Wikipedia</description>
  </link>
  <results_reference>
    <citation>Sharma A, Couture J. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother. 2014 Feb;48(2):209-25. doi: 10.1177/1060028013510699. Epub 2013 Nov 1. Review.</citation>
    <PMID>24259638</PMID>
  </results_reference>
  <results_reference>
    <citation>Aarts E, Ederveen THA, Naaijen J, Zwiers MP, Boekhorst J, Timmerman HM, Smeekens SP, Netea MG, Buitelaar JK, Franke B, van Hijum SAFT, Arias Vasquez A. Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS One. 2017 Sep 1;12(9):e0183509. doi: 10.1371/journal.pone.0183509. eCollection 2017.</citation>
    <PMID>28863139</PMID>
  </results_reference>
  <results_reference>
    <citation>Evangelisti M, De Rossi P, Rabasco J, Donfrancesco R, Lionetto L, Capi M, Sani G, Simmaco M, Nicoletti F, Villa MP. Changes in serum levels of kynurenine metabolites in paediatric patients affected by ADHD. Eur Child Adolesc Psychiatry. 2017 Dec;26(12):1433-1441. doi: 10.1007/s00787-017-1002-2. Epub 2017 May 19.</citation>
    <PMID>28527020</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 21, 2018</study_first_submitted>
  <study_first_submitted_qc>February 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Attention-deficit/hyperactivity disorder</keyword>
  <keyword>circulating metabolites</keyword>
  <keyword>metagenome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

